Govt gives validity extension of six months on registration certificate to pharma companies Read more
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData Read more
Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial Read more